meglumine has been researched along with Left Ventricular Hypertrophy in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (12.50) | 29.6817 |
| 2010's | 7 (87.50) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abdel-Gadir, A; Baig, S; Edwards, NC; Hughes, D; Kozor, R; Lachmann, RH; Lobascio, I; Medina-Menacho, K; Mehta, A; Moon, JC; Murphy, E; Nordin, S; Ramaswami, U; Sado, DM; Steeds, RP | 1 |
| Banypersad, SM; Ferreira, VM; Fontana, M; Hawkins, PN; Karamitsos, TD; Moon, JC; Myerson, SG; Neubauer, S; Ntusi, NB; Piechnik, SK; Robson, MD; Whelan, CJ | 1 |
| Banypersad, SM; Captur, G; Elliott, PM; Flett, AS; Fontana, M; Hughes, D; Lachmann, RH; Maestrini, V; Mehta, A; Moon, JC; Murphy, E; Neubauer, S; Piechnik, SK; Robson, MD; Sado, DM; Treibel, T; White, SK | 1 |
| Akkaya, M; Burgon, N; Damal, K; Erdogan, E; Higuchi, K; Kholmovski, E; Koopmann, M; Marrouche, NF; McGann, C | 1 |
| Hänninen, H; Heliö, T; Hiippala, A; Holmström, M; Kaasalainen, T; Kivistö, S; Ojala, T; Ollila, L; Pöyhönen, P; Tallila, J; Vasilescu, C | 1 |
| Bernardini, A; Bonomo, L; Cosentino, N; Crea, F; Lombardo, A; Natale, L; Niccoli, G | 1 |
| Antila, M; Heliö, T; Holmström, M; Jurkko, R; Kaartinen, M; Kärkkäinen, S; Kivistö, S; Koikkalainen, J; Kuusisto, J; Lauerma, K; Lötjönen, J; Peuhkurinen, K; Reissell, E | 1 |
| Kass, PH; Kittleson, MD; Klose, T; Larson, RF; MacDonald, KA; Wisner, ER | 1 |
8 other study(ies) available for meglumine and Left Ventricular Hypertrophy
| Article | Year |
|---|---|
Proposed Stages of Myocardial Phenotype Development in Fabry Disease.
Topics: Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Arrhythmias, Cardiac; Cardiomyopathies; Child; Contrast Media; Disease Progression; Fabry Disease; Female; Humans; Hypertrophy, Left Ventricular; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Myocardium; Organometallic Compounds; Phenotype; Predictive Value of Tests; Prognosis; Prospective Studies; Sex Characteristics; Sex Factors; Sphingolipids; Ventricular Function, Left; Ventricular Remodeling; Young Adult | 2019 |
Noncontrast T1 mapping for the diagnosis of cardiac amyloidosis.
Topics: Aged; Amyloidosis; Aortic Valve Stenosis; Cardiomyopathies; Case-Control Studies; Chi-Square Distribution; Contrast Media; Female; Humans; Hypertrophy, Left Ventricular; Magnetic Resonance Imaging, Cine; Male; Meglumine; Middle Aged; Myocardial Contraction; Myocardium; Organometallic Compounds; Predictive Value of Tests; Prognosis; Stroke Volume; Ventricular Function, Left | 2013 |
Identification and assessment of Anderson-Fabry disease by cardiovascular magnetic resonance noncontrast myocardial T1 mapping.
Topics: Adult; Aged; Aged, 80 and over; Analysis of Variance; Case-Control Studies; Contrast Media; Diagnosis, Differential; Fabry Disease; Female; Humans; Hypertrophy, Left Ventricular; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Myocardium; Organometallic Compounds; Predictive Value of Tests; Prospective Studies; Risk Factors; Young Adult | 2013 |
Relationship between left atrial tissue structural remodelling detected using late gadolinium enhancement MRI and left ventricular hypertrophy in patients with atrial fibrillation.
Topics: Aged; Atrial Fibrillation; Atrial Function, Left; Catheter Ablation; Chi-Square Distribution; Contrast Media; Female; Fibrosis; Heart Atria; Humans; Hypertrophy, Left Ventricular; Kaplan-Meier Estimate; Linear Models; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Multivariate Analysis; Organometallic Compounds; Predictive Value of Tests; Proportional Hazards Models; Recurrence; Retrospective Studies; Risk Factors; Time Factors; Treatment Outcome | 2013 |
Cardiovascular magnetic resonance findings in patients with PRKAG2 gene mutations.
Topics: Adolescent; Adult; AMP-Activated Protein Kinases; Cardiomyopathy, Hypertrophic; Contrast Media; DNA Mutational Analysis; Electrocardiography; Female; Fibrosis; Genetic Predisposition to Disease; Humans; Hypertrophy, Left Ventricular; Magnetic Resonance Imaging, Cine; Male; Meglumine; Middle Aged; Mutation; Myocardium; Organometallic Compounds; Phenotype; Predictive Value of Tests; Ventricular Function, Left; Ventricular Remodeling; Young Adult | 2015 |
Impact of microvascular obstruction and infarct size on left ventricular remodeling in reperfused myocardial infarction: a contrast-enhanced cardiac magnetic resonance imaging study.
Topics: Aged; Angioplasty, Balloon, Coronary; Contrast Media; Coronary Circulation; Echocardiography; Female; Humans; Hypertrophy, Left Ventricular; Logistic Models; Magnetic Resonance Imaging, Cine; Male; Meglumine; Microcirculation; Middle Aged; Multivariate Analysis; Myocardial Infarction; Myocardium; Odds Ratio; Organometallic Compounds; Predictive Value of Tests; Risk Assessment; Risk Factors; Rome; Time Factors; Treatment Outcome; Ventricular Remodeling | 2012 |
Late gadolinium enhanced cardiovascular magnetic resonance of lamin A/C gene mutation related dilated cardiomyopathy.
Topics: Adolescent; Adult; Cardiomyopathy, Dilated; Chi-Square Distribution; Contrast Media; Electrocardiography; Female; Fibrosis; Finland; Genetic Predisposition to Disease; Humans; Hypertrophy, Left Ventricular; Lamin Type A; Magnetic Resonance Imaging, Cine; Male; Meglumine; Middle Aged; Mutation; Myocardium; Organometallic Compounds; Phenotype; Predictive Value of Tests; Severity of Illness Index; Ventricular Dysfunction, Left; Ventricular Function, Left; Ventricular Function, Right | 2011 |
Comparison of myocardial contrast enhancement via cardiac magnetic resonance imaging in healthy cats and cats with hypertrophic cardiomyopathy.
Topics: Animals; Cardiomyopathy, Hypertrophic, Familial; Cat Diseases; Cats; Contrast Media; Echocardiography, Doppler; Heterocyclic Compounds; Hypertrophy, Left Ventricular; Linear Models; Magnetic Resonance Imaging; Meglumine | 2005 |